Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIS NASDAQ:JDOC NASDAQ:MEDX NASDAQ:TMED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBISProShares UltraShort Nasdaq Biotechnology$17.63-3.7%$17.33$15.90▼$36.85$2.47M-1.238,256 shs9,181 shsJDOCJPMorgan Healthcare Leaders ETF$55.25+0.5%$55.67$48.35▼$59.69$11.05M0.44912 shs521 shsMEDXHorizon Kinetics Medical ETF$33.48+0.9%$33.04$26.38▼$35.46$18.08M0.481,878 shs539 shsTMEDT. Rowe Price Health Care ETF$30.87+1.0%$30.05$23.46▼$31.75$20.07M1.762,972 shs2,762 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBISProShares UltraShort Nasdaq Biotechnology+6.08%+7.45%+2.75%+6.45%-50.46%JDOCJPMorgan Healthcare Leaders ETF0.00%-1.52%+1.18%-4.39%+11.85%MEDXHorizon Kinetics Medical ETF0.00%+0.03%+3.38%-3.31%+28.85%TMEDT. Rowe Price Health Care ETF0.00%+1.16%+4.39%+3.92%+3,128,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBISProShares UltraShort Nasdaq Biotechnology$17.63-3.7%$17.33$15.90▼$36.85$2.47M-1.238,256 shs9,181 shsJDOCJPMorgan Healthcare Leaders ETF$55.25+0.5%$55.67$48.35▼$59.69$11.05M0.44912 shs521 shsMEDXHorizon Kinetics Medical ETF$33.48+0.9%$33.04$26.38▼$35.46$18.08M0.481,878 shs539 shsTMEDT. Rowe Price Health Care ETF$30.87+1.0%$30.05$23.46▼$31.75$20.07M1.762,972 shs2,762 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBISProShares UltraShort Nasdaq Biotechnology+6.08%+7.45%+2.75%+6.45%-50.46%JDOCJPMorgan Healthcare Leaders ETF0.00%-1.52%+1.18%-4.39%+11.85%MEDXHorizon Kinetics Medical ETF0.00%+0.03%+3.38%-3.31%+28.85%TMEDT. Rowe Price Health Care ETF0.00%+1.16%+4.39%+3.92%+3,128,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBISProShares UltraShort Nasdaq Biotechnology 0.00N/AN/AN/AJDOCJPMorgan Healthcare Leaders ETF 2.77Moderate Buy$55.25N/AMEDXHorizon Kinetics Medical ETF 2.68Moderate Buy$33.48N/ATMEDT. Rowe Price Health Care ETF 2.82Moderate Buy$30.87N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBISProShares UltraShort Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AJDOCJPMorgan Healthcare Leaders ETFN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/ATMEDT. Rowe Price Health Care ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBISProShares UltraShort Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AN/AJDOCJPMorgan Healthcare Leaders ETFN/AN/A22.43N/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/A19.02N/AN/AN/AN/AN/AN/ATMEDT. Rowe Price Health Care ETFN/A-$1.36N/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBISProShares UltraShort Nasdaq Biotechnology$0.864.88%N/AN/AN/AJDOCJPMorgan Healthcare Leaders ETF$0.320.58%N/AN/AN/AMEDXHorizon Kinetics Medical ETF$0.501.49%N/AN/AN/ATMEDT. Rowe Price Health Care ETFN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBISProShares UltraShort Nasdaq BiotechnologyN/AJDOCJPMorgan Healthcare Leaders ETFN/AMEDXHorizon Kinetics Medical ETF62.18%TMEDT. Rowe Price Health Care ETFN/AInsider OwnershipCompanyInsider OwnershipBISProShares UltraShort Nasdaq BiotechnologyN/AJDOCJPMorgan Healthcare Leaders ETFN/AMEDXHorizon Kinetics Medical ETF4.30%TMEDT. Rowe Price Health Care ETF11.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBISProShares UltraShort Nasdaq BiotechnologyN/A140,000N/AOptionableJDOCJPMorgan Healthcare Leaders ETFN/A200,000N/AN/AMEDXHorizon Kinetics Medical ETFN/A540,000N/ANot OptionableTMEDT. Rowe Price Health Care ETFN/A650,000N/AN/AJDOC, BIS, MEDX, and TMED HeadlinesRecent News About These CompaniesWhen Eli Lilly Pivots, TMED's Strategy WinsMay 28, 2026 | etftrends.comET. Rowe Price Health Care ETF (NASDAQ:TMED) Shares Up 0.2% - Here's What HappenedMay 28, 2026 | americanbankingnews.comEyeing Healthcare Stocks? TMED Is Smashing Its BenchmarkApril 22, 2026 | etftrends.comEActive Healthcare ETF TMED Sending Buy SignalOctober 7, 2025 | etftrends.comEInvesting in Biotech? Look to Active for Index Performance DispersionSeptember 30, 2025 | etftrends.comEHow Active Sector ETFs Can Stand Out in Earnings SeasonAugust 13, 2025 | etftrends.comENew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 2026Nebius Group Pulls Back 9% After a Downgrade Despite Strong EarningsBy Ryan Hasson | May 19, 2026Nebius Upside Expands as AI Feedback Loop IntensifiesBy Thomas Hughes | May 13, 2026Nebius Breaks Out to All-Time Highs—Here's What's Driving It.By Ryan Hasson | May 5, 2026AI Consolidation Begins: Blackstone & Google Forge an AI EmpireBy Jeffrey Neal Johnson | May 20, 2026JDOC, BIS, MEDX, and TMED Company DescriptionsProShares UltraShort Nasdaq Biotechnology NASDAQ:BIS$17.63 -0.67 (-3.66%) Closing price 03:59 PM EasternExtended Trading$17.66 +0.03 (+0.16%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.JPMorgan Healthcare Leaders ETF NASDAQ:JDOC$55.25 +0.27 (+0.49%) As of 09:55 AM EasternThe JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.Horizon Kinetics Medical ETF NASDAQ:MEDX$33.48 +0.31 (+0.93%) As of 03:30 PM EasternThe Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics.T. Rowe Price Health Care ETF NASDAQ:TMED$30.87 +0.31 (+1.01%) As of 01:48 PM EasternThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The fund's investment portfolio concentrates primarily on health care equity. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Coke's $10B India IPO Plan Pops the Top on Hidden Value Palo Alto Networks Accelerates Growth 31% on AI Demand Motorola's $1.5B Bet to Own the Skies Microsoft Build 2026 Is Really Just One Big AI Stress Test FedEx Unboxes Billions in Post-Spinoff Value Slice of the Pie: Why Yum’s Deal Lifts QSR Urban Outfitters Stock Stalls Despite Another Strong Quarter What IBM's $10-Billion Quantum Project Means For Smaller Players Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
